[Phase II study with metastatic castration-resistant prostate cancer (mCRPC) patients]

Urologe A. 2017 Nov;56(11):1468-1470. doi: 10.1007/s00120-016-0299-7.
[Article in German]
No abstract available

Publication types

  • Clinical Trial, Phase II

MeSH terms

  • Humans
  • Male
  • Prostatic Neoplasms, Castration-Resistant*
  • Taxoids / therapeutic use

Substances

  • Taxoids